ReWalk Announced ReStore Exo-Suit for Stroke Rehabilitation
21 February, 2019
ReWalk anticipates commercializing the ReStore device for use by stroke patients and rehab clinics in Europe in mid-2019
ReWalk Robotics announced the submission of 510k application to the FDA for the ReStore exo-suit for gait training during stroke rehabilitation. The 510k application is a significant milestone in the process of commercialization.
Strokes are a major cause of serious long-term disability, with over 795,000 people suffering a stroke each year in the U.S. alone. Five million people are permanently disabled each year by strokes globally, according to the World Health Organization.
Unveiled in 2017, the ReStore soft exo-suit is designed to be a versatile, cost-effective gait therapy solution. The device also provides therapists the ability to adjust and optimize a patient’s treatment using real-time analytics.
The 510k submission follows the completion of a nationwide clinical study, with 44 patients enrolled across five rehabilitation centers in the United States. “As part of the multi-site study of the ReStore exo-suit, we applied the device to a broad range of individuals with post-stroke gait dysfunctions. The device allowed the study participants to walk effectively and efficiently, and we are encouraged with the potential of this technology to interact with and enhance everyday clinical care” explained Arun Jayaraman, PT, PhD who is Director of the Max Nader Lab for Rehabilitation Technologies & Outcomes Research at Shirley Ryan AbilityLab and lead investigator for the ReStore clinical study.
Following CE submission in Q4 of 2018, ReWalk anticipates commercializing the ReStore device for use by stroke patients and rehab clinics in Europe in mid-2019. In the United States a potential launch of the product could occur in late Q2 or Q3, pending clearance from the FDA.
How it works: The ReStore promotes an improved gait with coordinated plantarflexion and dorsiflexion assistance to a patient’s impaired foot and ankle. Power is transmitted from waist belt-mounted motors through cables to attachment points on the calf and an insole, which is placed in the patient’s shoe. Sensors clipped to the patient’s shoes detect motion and inform timing of the assistance. Using a handheld smartphone controller, a trained therapist is able to adjust assistance level, monitor key metrics such as session progress and gait symmetry, and record standard gait training assessments.
For more information: www.rewalk.com